Where is the live CopyMark page for USPTO serial 75226538?

The live record is at https://getcopymark.com/trademark/75226538. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns LEUKINE LIQUID?

According to the public USPTO record for serial number 75226538, the listed owner(s) include: IMMUNEX CORPORATION, IMMUNEX CORPORATION.

What is USPTO serial number 75226538?

Serial number 75226538 is the USPTO application identifier for the mark LEUKINE LIQUID. It is used to track examination, publication, and registration of this trademark.

What is the current status of LEUKINE LIQUID?

LEUKINE LIQUID (75226538) currently shows USPTO status code 606 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover LEUKINE LIQUID?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: LEUKINE LIQUID Serial# 75226538 | status 606; last event PC.D | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LEUKINE LIQUID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

IMMUNEX CORPORATION
Seattle, WA
Other trademarks owned by IMMUNEX CORPORATION
IMMUNEX CORPORATION
Seattle, WA
Other trademarks owned by IMMUNEX CORPORATION

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHRISTOPHER L WIGHT

CHRISTOPHER L WIGHT IMMUNEX CORPLAW DEPT51 UNIVERSITY STSEATTLE, WA 98101

Goods and services

Class	Description	Status	First use
005	biopharmaceutical preparations for use in the treatment of cancer and immune system diseases	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 13, 2000	PC.D	PETITION TO DIRECTOR DISMISSED	—
Oct 26, 1998	PCRC	PETITION TO DIRECTOR RECEIVED	—
Aug 20, 1998	EX1M	SOU EXTENSION 1 DENIAL LETTER MAILED	—
Aug 20, 1998	EX1D	SOU EXTENSION 1 DENIAL LETTER PREPARED	—
Aug 4, 1998	ABN6	ABANDONMENT - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 1998	EXT1	SOU EXTENSION 1 FILED	—
Feb 3, 1998	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 11, 1997	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 1997	NPUB	NOTICE OF PUBLICATION	—
Sep 12, 1997	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Sep 9, 1997	CNEA	EXAMINER'S AMENDMENT MAILED	—
Aug 1, 1997	DOCK	ASSIGNED TO EXAMINER	—

LEUKINE LIQUID